These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 26183651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J, Nunes-de-Souza RL.
    Brain Res; 2005 Jun 14; 1047(1):97-104. PubMed ID: 15893297
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ventrolateral periaqueductal gray lesion attenuates nociception but does not change anxiety-like indices or fear-induced antinociception in mice.
    Mendes-Gomes J, Amaral VC, Nunes-de-Souza RL.
    Behav Brain Res; 2011 Jun 01; 219(2):248-53. PubMed ID: 21238499
    [Abstract] [Full Text] [Related]

  • 5. Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.
    Baptista D, Nunes-de-Souza RL, Canto-de-Souza A.
    Behav Brain Res; 2012 Nov 01; 235(1):42-7. PubMed ID: 22800924
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Corticosterone does not change open elevated plus maze-induced antinociception in mice.
    Mendes-Gomes J, Miguel TT, Amaral VC, Nunes-de-Souza RL.
    Horm Behav; 2011 Sep 01; 60(4):408-13. PubMed ID: 21798262
    [Abstract] [Full Text] [Related]

  • 8. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
    Terzian AL, Aguiar DC, Guimarães FS, Moreira FA.
    Eur Neuropsychopharmacol; 2009 Mar 01; 19(3):188-95. PubMed ID: 19064314
    [Abstract] [Full Text] [Related]

  • 9. Open elevated plus maze-induced antinociception in rats: a non-opioid type of pain inhibition?
    Cornélio AM, Nunes-de-Souza RL.
    Physiol Behav; 2009 Mar 02; 96(3):440-7. PubMed ID: 19059275
    [Abstract] [Full Text] [Related]

  • 10. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis.
    Miguel TT, Nunes-de-Souza RL.
    Brain Res; 2006 Mar 03; 1076(1):42-8. PubMed ID: 16476419
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT, Nunes-de-Souza RL.
    Horm Behav; 2011 Aug 03; 60(3):292-300. PubMed ID: 21723867
    [Abstract] [Full Text] [Related]

  • 14. Environmentally induced antinociception and hyperalgesia in rats and mice.
    Cornélio AM, Mendes-Gomes J, Fugimoto JS, Morgan MM, Nunes-de-Souza RL.
    Brain Res; 2011 Sep 30; 1415():56-62. PubMed ID: 21880302
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
    Kincheski GC, Carobrez AP.
    Behav Brain Res; 2010 Jan 05; 206(1):120-6. PubMed ID: 19737580
    [Abstract] [Full Text] [Related]

  • 17. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids.
    Campos AC, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov 13; 33(8):1517-21. PubMed ID: 19735690
    [Abstract] [Full Text] [Related]

  • 18. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
    Casarotto PC, Terzian AL, Aguiar DC, Zangrossi H, Guimarães FS, Wotjak CT, Moreira FA.
    Neuropsychopharmacology; 2012 Jan 13; 37(2):478-86. PubMed ID: 21937980
    [Abstract] [Full Text] [Related]

  • 19. Anxiogenic effects of activation of NK-1 receptors of the dorsal periaqueductal gray as assessed by the elevated plus-maze, ultrasound vocalizations and tail-flick tests.
    Bassi GS, Nobre MJ, de Araújo JE, Brandão ML.
    Neuropeptides; 2007 Dec 13; 41(6):365-74. PubMed ID: 17981325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.